Learn About Beta-Mannosidosis

What is the definition of Beta-Mannosidosis?

Beta-mannosidosis is a rare inherited disorder affecting the way certain sugar molecules are processed in the body.

What are the causes of Beta-Mannosidosis?

Variants (also known as mutations) in the MANBA gene cause beta-mannosidosis. The MANBA gene provides instructions for making the enzyme beta-mannosidase. This enzyme works in the lysosomes, which are compartments that digest and recycle materials in the cell. Within lysosomes, the enzyme helps break down complexes of sugar molecules (oligosaccharides) attached to proteins (glycoproteins). Beta-mannosidase is involved in the last step of this process, helping to break down complexes of two sugar molecules (disaccharides) containing a sugar molecule called mannose.

How prevalent is Beta-Mannosidosis?

Beta-mannosidosis is believed to be a very rare disorder. It is difficult to determine the specific incidence of beta-mannosidosis, because people with mild or non-specific symptoms may never be diagnosed.

Is Beta-Mannosidosis an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have variants. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Beta-Mannosidosis Local Doctors?
Advanced in Beta-Mannosidosis
Geriatrics | Internal Medicine
Advanced in Beta-Mannosidosis
Geriatrics | Internal Medicine

Geriatric And Palliative Specialist PC

Oswego, NY 
 (94.9 mi)
Languages Spoken:
English
Offers Telehealth

Renante Ignacio is a Geriatrics specialist and an Internal Medicine provider in Oswego, New York. Dr. Ignacio and is rated as an Advanced provider by MediFind in the treatment of Beta-Mannosidosis. His top areas of expertise are Dementia, Anemia, Pericarditis, and Flu.

Experienced in Beta-Mannosidosis
Experienced in Beta-Mannosidosis
Lloyd Ln And Rte, Suite 42, 
Monticello, NY 
 (76.2 mi)
Languages Spoken:
English

Juan Goyzueta is a Nephrologist in Monticello, New York. Dr. Goyzueta and is rated as an Experienced provider by MediFind in the treatment of Beta-Mannosidosis. His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Diabetic Nephropathy, and Chronic Kidney Disease.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Beta-Mannosidosis
Geriatrics | Family Medicine | Internal Medicine
Advanced in Beta-Mannosidosis
Geriatrics | Family Medicine | Internal Medicine

St Joseph's Medical Practice PC

102 Park Ave, Suite 1, 
Yonkers, NY 
 (137.2 mi)
Languages Spoken:
English
Offers Telehealth

Nasem Sayegh is a Geriatrics specialist and an Internal Medicine provider in Yonkers, New York. Dr. Sayegh and is rated as an Advanced provider by MediFind in the treatment of Beta-Mannosidosis. His top areas of expertise are Type 1 Diabetes (T1D), Aspartylglucosaminuria, Schindler Disease, and Beta-Mannosidosis.

What are the latest Beta-Mannosidosis Clinical Trials?
MT2013-31: Allogeneic Hematopoietic Cell Transplantation for Inherited Metabolic Disorders and Severe Osteopetrosis Following Conditioning With Busulfan (Therapeutic Drug Monitoring), Fludarabine +/- ATG

Summary: This single-institution, phase II study is designed to test the ability to achieve donor hematopoietic engraftment while maintaining low rates of transplant-related mortality (TRM) using busulfan- and fludarabine-based conditioning regimens with busulfan therapeutic drug monitoring (TDM) for patients with various inherited metabolic disorders (IMD) and severe osteopetrosis (OP).

Match to trials
Find the right clinical trials for you in under a minute
Get started
Augmentation of Umbilical Cord Blood Transplantation for Inherited Metabolic Diseases with Intrathecal Administration of Human Umbilical Cord Blood-Derived Oligodendrocyte-Like Cells

Summary: The primary objective of the study is to determine the safety and feasibility of intrathecal administration of DUOC-01 as an adjunctive therapy in patients with inborn errors of metabolism who have evidence of early demyelinating disease in the central nervous system (CNS) who are undergoing standard treatment with unrelated umbilical cord blood transplantation (UCBT). The secondary objective of t...

Who are the sources who wrote this article ?

Published Date: February 01, 2023
Published By: National Institutes of Health